CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 36 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $4,000 | -42.9% | 10,060 | -56.7% | 0.00% | -100.0% |
Q3 2019 | $7,000 | -72.0% | 23,252 | -75.5% | 0.00% | 0.0% |
Q2 2019 | $25,000 | -83.3% | 94,842 | +266.8% | 0.00% | -88.9% |
Q3 2018 | $150,000 | +163.2% | 25,860 | +94.6% | 0.01% | +200.0% |
Q2 2018 | $57,000 | -63.7% | 13,288 | -53.5% | 0.00% | -62.5% |
Q3 2017 | $157,000 | – | 28,575 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|